Literature DB >> 3753514

Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization study.

P Chatelain, J Ferreira, R Laruel, J M Ruysschaert.   

Abstract

The effects of an antiarrhythmic and antianginal drug, amiodarone, on the physical state of membrane phospholipids was investigated by means of fluorescence polarization using the apolar probe 1,6 diphenyl-1,3,5-hexatriene incorporated in the hydrocarbon core. Multilamellar vesicles were prepared from neutral phospholipids (egg phosphatidylcholine, synthetic saturated phosphatidylcholine) alone or mixed with cholesterol or various lipids representative of the main lipid classes. Amiodarone reduces the temperature of the gel to liquid-crystalline phase transition and either increases or decreases lipid mobility in the gel or liquid-crystalline phase. In the gel state, the lipid mobility depends on drug concentration, degree of ionization and the length of the lipid acyl chains. In the liquid-crystalline state, the decreased lipid mobility which is concentration-dependent is essentially due to hydrophobic interactions. Amiodarone increases the lipid order parameter to the same extent as cholesterol. The data suggested that amiodarone is a rigid molecule deeply buried in the hydrocarbon core of the lipid and that amiodarone-lipid interactions are mainly hydrophobic.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753514     DOI: 10.1016/0006-2952(86)90379-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes.

Authors:  H Honjo; I Kodama; K Kamiya; J Toyama
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

2.  Inhibition of purified pig and human liver retinyl ester hydrolase by pharmacologic agents.

Authors:  R Schindler
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

3.  Antioxidant activity of amiodarone on human lipoprotein oxidation.

Authors:  D Lapenna; G Ciofani; C Bruno; S D Pierdomenico; F Cuccurullo
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

4.  Experimental and conformational analyses of interactions between butenafine and lipids.

Authors:  M P Mingeot-Leclercq; X Gallet; C Flore; F Van Bambeke; J Peuvot; R Brasseur
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology.

Authors:  G Morissette; A Ammoury; D Rusu; M C Marguery; R Lodge; P E Poubelle; F Marceau
Journal:  Br J Pharmacol       Date:  2009-07-07       Impact factor: 8.739

Review 6.  Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics.

Authors:  Shuchan Li; Jianrong Shi; Huifang Tang
Journal:  Cell Biol Toxicol       Date:  2021-11-05       Impact factor: 6.819

7.  Acute effects of amiodarone on membrane properties, refractoriness, and conduction in guinea pig papillary muscles.

Authors:  T Maruyama; L C Richardson; W Sun; J J McCarthy; L S Gettes
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

8.  Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats.

Authors:  Zuzana Matuskova; Eva Anzenbacherova; Rostislav Vecera; Helena Tlaskalova-Hogenova; Milan Kolar; Pavel Anzenbacher
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

9.  Amiodarone Provides Long-Lasting Local Anesthesia and Analgesia in Open-State Mouse Nociceptors.

Authors:  Masakazu Kotoda; Toru Matsuoka; Keiichi Wada; Selwyn Jayakar; Hirofumi Ino; Koji Kawago; Yasutomo Kumakura
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

10.  Visualization of Partial Exocytotic Content Release and Chemical Transport into Nanovesicles in Cells.

Authors:  Tho Duc Khanh Nguyen; Lisa Mellander; Alicia Lork; Aurélien Thomen; Mai Philipsen; Michael E Kurczy; Nhu T N Phan; Andrew G Ewing
Journal:  ACS Nano       Date:  2022-02-21       Impact factor: 15.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.